Cargando…

Association of metabolic‐associated fatty liver disease and risk of severe coronavirus disease 2019 illness

Given the global health burden caused by the Coronavirus Disease 2019 (COVID‐19), there have been numerous studies aimed to understand its clinical course and to determine risk factors that may impact prognosis. Pre‐existing medical conditions are linked with COVID‐19 severity, particularly cardiome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sy‐Janairo, Marianne Linley, Y Cua, Ian Homer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753749/ https://www.ncbi.nlm.nih.gov/pubmed/33363258 http://dx.doi.org/10.1002/jgh3.12465

Ejemplares similares

Data on the sequence-derived properties of gastric cancer – binding peptides
por: Janairo, Jose Isagani B., et al.
Publicado: (2020)

Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight
por: Vasques-Monteiro, Isabela Macedo Lopes, et al.
Publicado: (2021)

Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019
por: Gao, Feng, et al.
Publicado: (2021)

Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management
por: Xu, Yanlan, et al.
Publicado: (2021)

COVID‐19 and its effects on the digestive system and endoscopy practice
por: Aguila, Enrik John T., et al.
Publicado: (2020)

Interaction of metabolic dysfunction‐associated fatty liver disease and nonalcoholic fatty liver disease with advanced fibrosis in the death and intubation of patients hospitalized with coronavirus disease 2019
por: Vázquez‐Medina, Martín Uriel, et al.
Publicado: (2022)

Coronavirus disease 2019 and non-alcoholic fatty liver disease
por: Bellanti, Francesco, et al.
Publicado: (2021)

Is Fatty Liver Associated with Increased Mortality and Morbidity in Coronavirus Disease 2019 (COVID-19) Pneumonia?
por: Madan, Kaushal, et al.
Publicado: (2022)

The Impact of Nonalcoholic Fatty Liver Disease on the Outcomes of Coronavirus Disease 2019 Infection
por: Asemota, Joseph, et al.
Publicado: (2022)

Metabolic-associated Fatty Liver Disease
por: Zheng, Ming-Hua
Publicado: (2021)

The evidence is in that asthma is not associated with severe coronavirus disease 2019
por: Timberlake, Dylan T., et al.
Publicado: (2021)

Lymphocytes and Eosinophils Associated with the Coronavirus Disease-2019 Severity
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Role of fatty liver in coronavirus disease 2019 patients’ disease severity and hospitalization length: a case–control study
por: Ziaee, Arash, et al.
Publicado: (2021)

Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease
por: Huang, Jee-Fu, et al.
Publicado: (2023)

Gut microbiome profiles associated with steatosis severity in metabolic associated fatty liver disease
por: Dong, Tien S., et al.
Publicado: (2021)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Metabolic-associated fatty liver disease and lipoprotein metabolism
por: Heeren, Joerg, et al.
Publicado: (2021)

Macrophages in metabolic associated fatty liver disease
por: Alharthi, Jawaher, et al.
Publicado: (2020)

Alcohol and Metabolic-associated Fatty Liver Disease
por: Sun, Fu-Rong, et al.
Publicado: (2021)

Mitochondrial DNA methylation in metabolic associated fatty liver disease
por: Mposhi, Archibold, et al.
Publicado: (2023)

Laboratory Findings Associated With Severe Illness and Mortality Among Hospitalized Individuals With Coronavirus Disease 2019 in Eastern Massachusetts
por: Castro, Victor M., et al.
Publicado: (2020)

Laboratory findings associated with severe illness and mortality among hospitalized individuals with coronavirus disease 2019 in Eastern Massachusetts
por: Castro, Victor M., et al.
Publicado: (2020)

Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020
por: Gupta, Nivedita, et al.
Publicado: (2020)

Delirium Incidence, Duration, and Severity in Critically Ill Patients With Coronavirus Disease 2019
por: Khan, Sikandar H., et al.
Publicado: (2020)

Coronavirus disease 2019 pandemic: Do not forget patients with severe mental illness
por: Mousavi, S. Bentolhoda
Publicado: (2020)

RE: Lymphocytes and Eosinophils Associated with the Coronavirus Disease-2019 Severity
por: Duman, Dildar, et al.
Publicado: (2023)

Dexmedetomidine-Associated Hyperpyrexia in Three Critically Ill Patients With Coronavirus Disease 2019
por: Czepiel, Kathryn S., et al.
Publicado: (2020)

Problems and Challenges Associated with Renaming Non-alcoholic Fatty Liver Disease to Metabolic Associated Fatty Liver Disease
por: Zeng, Minghui, et al.
Publicado: (2023)

Redefining non-alcoholic fatty liver disease to metabolic associated fatty liver disease: Is this plausible?
por: Devi, Jalpa, et al.
Publicado: (2022)

A predictive model for disease progression in non-severely ill patients with coronavirus disease 2019
por: Ji, Mengyao, et al.
Publicado: (2020)

Thyroid disease is associated with severe coronavirus disease 2019 (COVID-19) infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2020)

Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19
por: Sharma, Praveen, et al.
Publicado: (2020)

From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
por: Kang, Seong Hee, et al.
Publicado: (2021)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Different barriers to nutritional therapy among critically-ill patients with COVID-19
por: Aguila, Enrik John T., et al.
Publicado: (2021)

An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease
por: Rodríguez-Sanabria, J. Samael, et al.
Publicado: (2022)

Infections at the nexus of metabolic-associated fatty liver disease
por: Boeckmans, Joost, et al.
Publicado: (2021)

Biochemical assessment of metabolic associated fatty liver disease
por: Guerra-Ruiz, Armando R., et al.
Publicado: (2021)

Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019
por: Rubin, Sébastien, et al.
Publicado: (2020)

An Algorithm for Classifying Patients Most Likely to Develop Severe Coronavirus Disease 2019 Illness
por: Kattan, Michael W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ci24h5aeju07ggg2jt44qatnar